SKI Market

Indian Indices

Sensex

80,015.90 899.71
( 1.14%)

Global Indices

Nasdaq

48,766.17 243.89
(0.50%)

Dow Jones

6,891.51 53.88
(0.79%)

Hang Seng

55,141.42 895.88
(1.65%)

Nikkei 225

10,430.91 -136.74
(-1.29%)

Forex

USD-INR

91.96 0.48
(0.52%)

EUR-INR

106.94 -0.34
(-0.32%)

GBP-INR

122.70 0.09
(0.07%)

JPY-INR

0.58 0.00
(0.18%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hindustan Construction Company Ltd

Industry : Construction

BSE Code

ISIN Demat

Book Value()

500185

INE549A01026

11.4226149

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HCC

12.04

4259.26

EPS(TTM)

Face Value()

Div & Yield %

1.35

Back

mpil corporation ltd

ERIS Lifesciences board approves acquisition of balance 30% stake in Swiss Parenterals

Nov 24,2025

The board of ERIS Lifesciences at its meeting held on 24 November 2025 has approved the acquisition of balance 30% of the total share capital of Swiss Parenterals, a subsidiary of the Company.

Further, the board has approved the issuance of up to 23,06,372 equity shares of the Company on preferential basis to discharge the consideration for acquisition of 30% stake in Swiss Parenterals.

80,015.90 899.71 ( 1.14%)

48,766.17 243.89 (0.50%)

6,891.51 53.88 (0.79%)

55,141.42 895.88 (1.65%)

10,430.91 -136.74 (-1.29%)

91.96 0.48 (0.52%)

106.94 -0.34 (-0.32%)

122.70 0.09 (0.07%)

0.58 0.00 (0.18%)